VINGRAF 1

Vingraf 1 Capsule is utilized to avert the rejection of a transplanted organ, such as a liver, kidney, or heart. Organ rejection happens when a patient’s immune system identifies the donor organ as foreign and attempts to eliminate it.

Vingraf 1 Capsule contains Tacrolimus, which functions by inhibiting the activity of T and B lymphocytes (cells in the immune system) that typically attack foreign invaders and protect the body against foreign cells and infections. Consequently, it prevents organ rejection in transplant patients and assists the body in accepting the new organ.

Take Vingraf 1 Capsule as directed. It is recommended to use Vingraf 1 Capsule for the duration your doctor has advised based on your medical condition. Some individuals may experience nausea, diarrhea, headaches, kidney issues, infections, fever, constipation, or elevated blood pressure. Most of these side effects associated with Vingraf 1 Capsule do not necessitate medical attention and typically resolve over time. However, if the side effects persist or worsen, please consult your physician.

If you have an allergy to Tacrolimus or any other medications, please inform your doctor. If you are pregnant or a breastfeeding mother, it is advisable to consult a physician before using Vingraf 1 Capsule. Avoid consuming alcohol while taking Vingraf 1 Capsule. Drive only if you are alert, as Vingraf 1 Capsule may cause vision problems or nervous disturbances in some individuals. If you are about to receive a vaccination, notify your doctor before taking Vingraf 1 Capsule. Vingraf 1 Capsule may elevate the risk of infections or skin cancer as it diminishes the body’s immune defense system.